Northwest Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	301	358	364	822	830	663
Market Cap Growth	-17.74%	-1.53%	-55.72%	-1.00%	25.14%	-47.13%
Enterprise Value	376	444	435	881	865	686
Last Close Price	0.18	0.23	0.27	0.70	0.78	0.70
PE Ratio	-	-	-	-	-	3.70
PS Ratio	201.28	260.08	263.35	425.38	493.23	660.04
PB Ratio	-7.92	-7.53	-4.61	-17.47	-7.90	-5.35
EV/Sales Ratio	251.18	322.41	314.92	455.93	513.96	682.10
Debt / Equity Ratio	-1.68	-1.36	-0.85	-0.97	-0.25	-0.31
Net Debt / Equity Ratio	-1.63	-1.30	-0.83	-0.92	-0.18	-0.18
Net Debt / EBITDA Ratio	-1.22	-1.07	-1.01	-0.80	-0.29	-0.43
Net Debt / FCF Ratio	-1.26	-1.33	-1.12	-0.76	-0.35	-0.51
Asset Turnover	0.03	0.03	0.05	0.07	0.05	0.03
Quick Ratio	0.02	0.03	0.03	0.05	0.06	0.11
Current Ratio	0.08	0.06	0.06	0.09	0.08	0.13
Return on Assets (ROA)	-62.18%	-69.33%	-152.28%	-117.23%	-117.48%	-90.17%
Return on Capital Employed (ROCE)	1831.00%	575.50%	160.10%	320.10%	71.00%	56.30%
Earnings Yield	-15.02%	-16.79%	-23.02%	-7.62%	-12.65%	27.00%
FCF Yield	-16.39%	-12.91%	-15.95%	-6.94%	-6.71%	-6.68%
Buyback Yield / Dilution	-17.74%	-17.26%	-10.99%	-10.17%	-0.79%	-38.99%